AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiauk M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Auk Lifecare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimiauk M 2mg/500mg Tablet

Diabexe Duo 2mg/500mg tablets are classified as antidiabetic agents, a combination medication for adult-onset type 2 diabetes. This dual-action formulation helps regulate blood glucose. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications including nephropathy, retinopathy, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, lightheadedness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or lactation. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glimiauk M 2mg/500mg Tablet

No text provided to rephrase.

Uses of Glimiauk M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimiauk M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimiauk M 2mg/500mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimiauk M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiauk M 2mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the Glimiauk M 2mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Glimiauk M 2mg/500mg Tablet works:

Glimiauk M 2mg/500mg tablets contain glimepiride and metformin, two medications that work together to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and improving the body's response to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimiauk M 2mg/500mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimiauk M 2mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Maternal use of Glimiauk M 2mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimiauk M 2mg/500mg Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use of Glimiauk M 2mg/500mg Tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimiauk M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. In individuals with mild to moderate hepatic dysfunction, Glimiauk M 2mg/500mg tablets are typically initiated at a low dose; however, their use is contraindicated in those with severe liver disease.

What if you forget to take Glimiauk M 2mg/500mg Tablet :

Should you forget a Glimiauk M 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimiauk M 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimiauk M 2mg/500mg Tablet

Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Glimiauk M 2mg/500mg Tablet. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with kidney impairment, the elderly, and those who consume substantial alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia warrant immediate discontinuation of Glimiauk M 2mg/500mg Tablet and prompt medical attention.
Glimiauk M 2mg/500mg tablets contain glimepiride and metformin, two medications combined to manage type 2 diabetes mellitus in adults. This treatment enhances blood sugar control when coupled with a suitable diet and regular physical activity. Glimepiride functions by stimulating the pancreas to release more insulin, thus reducing blood glucose. Metformin reduces hepatic glucose production and improves the body's response to insulin. This formulation is unsuitable for treating type 1 diabetes.
Glimiauk M 2mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse events such as lactic acidosis can also occur. Prolonged use might result in vitamin B12 deficiency.
Prolonged Glimiauk M 2mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive measures, including supplemental Vitamin B12 at least annually, are recommended by some studies.
Indeed, Glimiauk M 2mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, increased appetite, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a rapidly absorbable sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimiauk M 2mg/500mg tablets and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol consumption also raises the likelihood of lactic acidosis.
Glimiauk M 2mg/500mg Tabl...
39
MRP 47
17% off